Archer-Daniels-Midland returns to the earnings window on August 4 in a materially different position than it occupied a week ago — the stock has given back nearly all of its recent gains and now trades below the mean analyst price target.
The reversal is the defining feature of the current setup. ADM closed at $79.27 on July 31, down 7.7% on the week and 1.7% on Friday alone. That moves the stock closer to the $75.50 consensus target — and, critically, below the $85.92 level at which the previous earnings preview noted the Street's deep scepticism. The Q2 print on July 28 delivered a 3.4% one-day drop, which reset the discussion entirely. Short interest has pulled back sharply — down nearly 10% over the week to 3.3% of the free float — suggesting short sellers trimmed into the weakness rather than pressing new bets. The lending market is extraordinarily loose, with availability running at more than 16 times outstanding short interest, and borrowing costs a minimal 0.48%. There is no squeeze pressure here. Options positioning has edged slightly more defensive, with the put/call ratio at 0.49 versus a 20-day average of 0.47 — a 1.8 standard-deviation move above the mean, but still modest in absolute terms.
The analyst debate has sharpened now that the stock has corrected. Morgan Stanley's Underweight target of $60 looked aggressive when ADM was trading at $86; at $79, the gap is narrowing. JP Morgan holds a $74 Underweight target — ADM is now trading only $5 above it. That pair of underweight calls from major firms now frames a genuine downside case. UBS, with a $95 Buy target, remains the bull anchor, pointing to constructive commodity dynamics and EPS momentum that ranks in the 93rd percentile on a 90-day basis. Forward EPS growth ranks in the 89th percentile of the broader universe. The EV/EBITDA multiple has drifted lower over the past month, which the bulls read as the earnings base catching up to price. Bears counter that the PE has still expanded and margins have yet to deliver a clean recovery. The mean target of $75.50 now implies modest downside from current levels — a far tighter spread than existed seven days ago.
Institutional ownership is stable and concentrated. BlackRock and State Street added shares through June 30, while State Farm, the largest holder at 9.7% of shares, was unchanged as of March 31. The ownership base shows no sign of distress. The close peer BG dropped 14% on the week — a steeper decline than ADM's own 7.7% — which removes one potential read-through and suggests sector-wide commodity pressure rather than an ADM-specific selloff.
The August 4 print will test whether ADM's EPS momentum — the metric bulls have most consistently cited — holds up under what has become a tighter valuation conversation, with key bear-camp targets now only a single-digit percentage below the current price.
See the live data behind this article on ORTEX.
Open ADM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
ADM has gained 16% in a month, with the Street finally moving in the same direction. The catalyst is clear: ADM reported Q1 results on May 5th and the stock rose 2.3% on the day, extending to a near 6% five-session…
Archer-Daniels-Midland enters its Q1 2026 earnings call — scheduled for May 7 — with the stock up 9% on the week, the Street raising targets across the board, and shorts building quietly in the background. The…
